TP53 and mismatch repair cancer syndrome 1: The recently published version of the National Comprehensive Cancer Network guidelines encourages molecular assessment of EC and states that probing for POLE hotspot variations and performing immunohistochemical analysis of mismatch repair deficiency and wild-type TP53 expression may identify MSI-H and NSMP, respectively (36).